FIELD: medicine.
SUBSTANCE: invention aims at assessing an efficacy of therapeutic agents (TA) for improving individual's cognitive functions. The patient's blood serum is examined for the HLDF protein, titres of idiotypic and anti-idiotypic HLDF antibodies before and after the TA is administered, and the above derived data are used to calculate MMSE before and after the TA is administered by formula; the derived MMSEs are compared, and the TA efficacy is assessed by the comparison result.
EFFECT: invention enables more real-time selection of one or another TA or the length of the course of administration, including the real-time prescription of this course if the patient's condition deteriorates.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MOLECULAR DIAGNOSTIC TECHNIQUE FOR PSYCHOSOMATIC FUNCTION STATE IN PATIENTS WITH DISCIRCULATORY ENCEPHALOPATHY | 2012 |
|
RU2531922C2 |
| METHOD FOR ASSESSING THE EFFECTIVENESS OF CHEMOPREVENTIVE ACTIVITY OF RESVERATROL IN EXPERIMENTAL CARCINOGENESIS OF LIVER CANCER | 2020 |
|
RU2736238C1 |
| AGENT AND METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE | 2008 |
|
RU2384343C2 |
| NEUROTROPIC DRUG AND METHOD OF TREATING STRUCTURAL DISEASES OF NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHIES OF VARIOUS ORIGINS | 2011 |
|
RU2536234C2 |
| THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE AND METHOD OF TREATING ALZHEIMER'S DISEASE | 2011 |
|
RU2536232C2 |
| METHOD FOR INCREASING PHARMACOLOGICAL ACTIVITY OF ACTIVE SUBSTANCE OF MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION | 2014 |
|
RU2572706C1 |
| PEPTIDE HAVING NEUROPROTECTIVE AND NOOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2557003C2 |
| METHOD FOR PREDICTING RISK OF DEATH AT HOSPITAL STAGE IN PATIENTS WITHOUT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION WHO HAVE UNDERGONE NEW COVID-19 CORONAVIRUS INFECTION, TAKING INTO ACCOUNT THEIR IMMUNOLOGICAL STATUS | 2022 |
|
RU2781565C1 |
| COMPOSITION CONTAINING AMYLOIDAL PEPTIDE Aβ-1-6 ATTACHED TO VIRUS-LIKE PARTICLE AND ADJUVANT | 2011 |
|
RU2603486C2 |
| METHOD OF PREDICTION OF COGNITIVE DISORDERS IN PATIENTS WITH BRAIN CONCUSION AND MINOR BRAIN INJURY | 2023 |
|
RU2803276C1 |
